Axxcess Wealth Management LLC Has $309,000 Stake in Aflac Incorporated (NYSE:AFL)

Axxcess Wealth Management LLC trimmed its position in shares of Aflac Incorporated (NYSE:AFL) by 51.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,988 shares of the financial services provider’s stock after selling 3,155 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Aflac were worth $309,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Whipplewood Advisors LLC acquired a new stake in shares of Aflac during the 4th quarter valued at about $26,000. BankPlus Trust Department acquired a new stake in Aflac in the 4th quarter worth approximately $34,000. Curio Wealth LLC acquired a new stake in Aflac in the 4th quarter worth approximately $36,000. Raelipskie Partnership acquired a new stake in Aflac in the 3rd quarter worth approximately $38,000. Finally, OFI Invest Asset Management acquired a new stake in Aflac in the 4th quarter worth approximately $38,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Stock Performance

AFL opened at $108.10 on Friday. The stock has a market cap of $59.08 billion, a PE ratio of 11.26, a P/E/G ratio of 3.24 and a beta of 0.93. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1 year low of $79.31 and a 1 year high of $115.50. The stock’s 50 day simple moving average is $105.95 and its 200-day simple moving average is $107.63.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Sell-side analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Analyst Upgrades and Downgrades

AFL has been the subject of several analyst reports. JPMorgan Chase & Co. boosted their target price on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Wells Fargo & Company dropped their price target on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 19th. Barclays dropped their price target on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, February 7th. Finally, Keefe, Bruyette & Woods dropped their price target on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Aflac presently has a consensus rating of “Hold” and an average target price of $103.36.

Insider Buying and Selling at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the company’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares in the company, valued at $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 55,546 shares of company stock worth $5,863,616 over the last three months. Company insiders own 0.80% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.